Generic empagliflozin
Phase 1Small molecule
Generic empagliflozin is one of 6 small molecule programs targeting Empagliflozin. It is currently in Phase 1.
1
Indications
1
Total Trials
1
Active Trials
5
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
6 competitors in Empagliflozin
#DrugCompanyPhaseTrials
1Jardiance
Boehringer IngelheimApproved
Glucophage
EMD SeronoApproved
Coumadin
AAbbott
Phase 1
Versed
CConrado Roberto Hoffmann Filho
Phase 1
HDM1002
HHangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 1
Generic empagliflozin
IInternational Bio service
Phase 1
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Generic empagliflozin. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 1[1]
- Company
- IInternational Bio service